Skip to content

Vaginal Wound Infiltration Analgesia for Postoperative Pain After Laparoscopic Hysterectomy: a Randomized Trial

Vaginal Wound Infiltration Analgesia for Postoperative Pain After Laparoscopic Hysterectomy: a Randomized Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02767544
Enrollment
81
Registered
2016-05-10
Start date
2014-11-30
Completion date
2016-10-31
Last updated
2016-05-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Pain

Keywords

laparoscopic hysterectomy, postoperative pain, local analgesia, vaginal wound

Brief summary

In cases of laparoscopic hysterectomy , women were randomized to two groups: ropivacaine ( vaginal wound infiltration analgesia) vs. control group. Results regarding postoperative pain and need of oxycodone.

Detailed description

Women assigned to laparoscopic hysterectomy were randomly divided into two groups as regard surgery: a ropivacaine group (RG) (n=41) and a control group (CG) (n=40). General anesthesia and use of local anesthetics were standardized. Visual analog scale (VAS) scores for pain and side effects (nausea/vomiting) and the amount of postoperative analgesic used were recorded for 24 hours.

Interventions

PROCEDUREVaginal wound local analgesia after laparoscopic hysterectomy

Sponsors

Helsinki University Central Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Age
30 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

The criteria for inclusion were scheduled laparoscopic hysterectomy

Exclusion criteria

The

Design outcomes

Primary

MeasureTime frameDescription
Postoperative pain scoresChange in 24 hours after surgeryVisual Analog Score (VAS) for pain. Physicians Global Assessment to measure quality of pain. 10-point VAS score for pain (0-10), 0 indicating no pain and 10 indicating unbearable pain at 1,3,6,12 and 24 h (hour) after surgery (Units on a Scale; 0-10).

Secondary

MeasureTime frameDescription
ComplicationUp to one weekFrequency of complications. Values are given as n (%) and eventual complications are specified.
NauseaChange in 24 hours after surgery.Nausea after the procedure: Visual Analog Score (VAS) for nausea. Physicians Global Assessment to measure quality of nausea. 10-point VAS score for nausea (0-10), 0 indicating no nausea and 10 indicating unbearable nausea at 1,3,6,12 and 24 h (hour) after surgery. ( Unit on scale; 0-10).
Length of hospitalisationUp to one weekLength of hospital stay measured from the end of the operation until discharge
The use of analgesics for postoperative painChange in 24 hours after surgeryPostoperative pain defined by the total amount of analgesics used. Amount of used Oxycodone (mg).
VomitingChange in 24 hours after surgery.Vomiting after the procedure: Visual Analog Score (VAS) for vomiting. Physicians Global Assessment to measure quality of vomiting. 10-point VAS score for vomiting (0-10), 0 indicating no vomiting and 10 indicating unbearable vomiting at 1,3,6,12 and 24 h (hour) after surgery. ( Unit on scale; 0-10).

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026